Please ensure Javascript is enabled for purposes of website accessibility

Here's Why Invitae Got Crushed Today

By Maxx Chatsko – May 8, 2019 at 12:30PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The genetic testing leader and Wall Street weren't on the same page for first-quarter 2019 revenue.

What happened

Shares of Invitae (NVTA -1.02%) fell nearly 20% today after the company reported first-quarter 2019 operating results. The business remains on track to exceed its full-year 2019 revenue guidance of $220 million, according to management. But Wall Street was embarrassed by its expectation for $47 million in revenue during the opening quarter of the year. The company reported just $40.5 million. 

Aside from that discrepancy, the genetic testing leader made progress on multiple fronts. It expanded the number of direct sales to patients, reduced cost of goods sold, and captured a 101% year-over-year increase in gross profit. All of the increase was poured into swelling operating expenses, but that's hardly a surprise considering Invitae is furiously investing in growth opportunities.

As of 11:38 a.m. EDT, the stock had settled to a 17% loss.

A stick figure trying to pull a falling arrow up.

Image source: Getty Images.

So what

CFO Shelly Guyer noted a few reasons for the lower-than-expected revenue total on the first-quarter 2019 earnings conference call. There were lower one-time purchases of tests during the quarter, while lower rates of reimbursement from Medicare kicked in at the beginning of January. Meanwhile, selling tests directly to patients is great for growth, but it lowers the average selling price per sample.

While the direct-to-consumer efforts comprise the bulk of the company's growth strategy, Invitae did deliver a 19% year-over-year reduction in cost of goods sold in Q1 2019. That helped to drive gross profit and gross margin higher and keep operating losses in check.

Now what

Considering management kept its full-year 2019 guidance intact and thinks the business is on pace to top it, Invitae must be on the cusp of some incredible surges in revenue in the coming quarters. More impressively, management thinks the business can achieve more than $500 million in revenue in 2020. That would mark a more than doubling of revenue from this year to next and would likely get the company to profitable operations. Now the business just has to execute.

Maxx Chatsko has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Invitae Stock Quote
Invitae
NVTA
$2.44 (-1.02%) $0.03

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
326%
 
S&P 500 Returns
102%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/03/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.